SG11201405721VA - Method of producing a recombinant peptide - Google Patents
Method of producing a recombinant peptideInfo
- Publication number
- SG11201405721VA SG11201405721VA SG11201405721VA SG11201405721VA SG11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA
- Authority
- SG
- Singapore
- Prior art keywords
- producing
- recombinant peptide
- recombinant
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261612817P | 2012-03-19 | 2012-03-19 | |
PCT/AU2013/000273 WO2013138850A1 (en) | 2012-03-19 | 2013-03-19 | Method of producing a recombinant peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201405721VA true SG11201405721VA (en) | 2014-10-30 |
Family
ID=49221695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201405721VA SG11201405721VA (en) | 2012-03-19 | 2013-03-19 | Method of producing a recombinant peptide |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150315259A1 (en) |
EP (1) | EP2839010B1 (en) |
JP (1) | JP2015510770A (en) |
KR (1) | KR20140148420A (en) |
CN (2) | CN104364378A (en) |
AU (2) | AU2013234860B2 (en) |
SG (1) | SG11201405721VA (en) |
WO (1) | WO2013138850A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8947194B2 (en) | 2009-05-26 | 2015-02-03 | Solaredge Technologies Ltd. | Theft detection and prevention in a power generation system |
AU2019245333A1 (en) * | 2018-03-29 | 2020-10-29 | Contrafect Corporation | Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria |
CN113121637B (en) * | 2020-01-15 | 2022-06-14 | 鲁南制药集团股份有限公司 | Separation and purification method of recombinant protein |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691310A (en) * | 1987-09-29 | 1997-11-25 | Vesely; David L. | Methods of treatment using proANF peptides |
GB9716790D0 (en) * | 1997-08-07 | 1997-10-15 | Creative Peptides Sweden Ab | Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof |
CN1242062C (en) * | 1998-07-10 | 2006-02-15 | 赛欧斯公司 | Method for producing a peptide with a pi above 8 or below 5 |
AU5762699A (en) * | 1998-09-19 | 2000-04-10 | Sang Jun Lee | Dna cassette encoding a multimer of a biologically active peptide and a cleavable linker attached thereto and process for preparing the biologically active peptide |
US6759510B1 (en) * | 2000-06-30 | 2004-07-06 | Becton, Dickinson And Company | Peptides for use in culture media |
CN1363654A (en) * | 2001-07-19 | 2002-08-14 | 上海华谊生物技术有限公司 | Genetically engineered bacteria and process for preparing insulinotropic hormone secretion peptide GLP-1 (7-36) |
EP1532261B1 (en) * | 2002-05-24 | 2010-02-10 | Medtronic, Inc. | Methods and dna constructs for high yield production of polypeptides |
CN100558398C (en) * | 2002-11-26 | 2009-11-11 | 拜奥康有限公司 | Natriuresis chemical compound, conjugate and the application thereof of modifying |
EP1727556A2 (en) * | 2004-02-17 | 2006-12-06 | University Of South Florida | Materials and methods for treatment of inflammatory and cell proliferation disorders |
DE602005004902T2 (en) * | 2005-06-02 | 2008-10-16 | Entelechon Gmbh | Artificial protein, method for absolute quantification of proteins and its use |
WO2009043526A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
RU2451750C2 (en) * | 2007-09-24 | 2012-05-27 | Общество С Ограниченной Ответственностью "Герофарм" | Method of producing recombinant human proinsulin c-peptide |
US8527211B2 (en) * | 2008-06-18 | 2013-09-03 | Reza Zareie | Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization |
AU2010297011A1 (en) * | 2009-09-18 | 2012-04-12 | Selexis S.A. | Products and methods for enhanced transgene expression and processing |
US9018168B2 (en) * | 2010-08-12 | 2015-04-28 | Madeleine Pharmaceuticals Pty Ltd | Therapeutic method for treating congestive heart failure |
WO2012115772A2 (en) * | 2011-02-25 | 2012-08-30 | Medtronic, Inc. | Therapy for kidney disease and/or heart failure |
-
2013
- 2013-03-19 AU AU2013234860A patent/AU2013234860B2/en not_active Ceased
- 2013-03-19 JP JP2015500714A patent/JP2015510770A/en active Pending
- 2013-03-19 CN CN201380025049.6A patent/CN104364378A/en active Pending
- 2013-03-19 SG SG11201405721VA patent/SG11201405721VA/en unknown
- 2013-03-19 CN CN201710409638.4A patent/CN107266554A/en active Pending
- 2013-03-19 WO PCT/AU2013/000273 patent/WO2013138850A1/en active Application Filing
- 2013-03-19 EP EP13765199.8A patent/EP2839010B1/en active Active
- 2013-03-19 US US14/385,402 patent/US20150315259A1/en not_active Abandoned
- 2013-03-19 KR KR1020147029054A patent/KR20140148420A/en not_active Application Discontinuation
-
2016
- 2016-02-29 AU AU2016100212A patent/AU2016100212A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20150315259A1 (en) | 2015-11-05 |
KR20140148420A (en) | 2014-12-31 |
CN107266554A (en) | 2017-10-20 |
JP2015510770A (en) | 2015-04-13 |
CN104364378A (en) | 2015-02-18 |
AU2013234860B2 (en) | 2016-01-21 |
AU2013234860A1 (en) | 2014-10-16 |
WO2013138850A1 (en) | 2013-09-26 |
EP2839010B1 (en) | 2018-04-25 |
EP2839010A1 (en) | 2015-02-25 |
EP2839010A4 (en) | 2015-12-09 |
AU2016100212A4 (en) | 2016-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2873677A4 (en) | Method of producing self-assembling peptide derivative | |
SG11201400432VA (en) | Polypeptide vaccine | |
EP2690108A4 (en) | Novel immunoglobulin-binding polypeptide | |
SG11201504694VA (en) | Method for producing a recombinant protein of interest | |
HK1209790A1 (en) | Method of producing recombinant iduronate-2-sulfatase -2- | |
HK1195791A1 (en) | A polypeptide | |
HK1223980A1 (en) | Improved recombinant polypeptide production methods | |
IL239737A0 (en) | Method of producing a protein | |
EP2804488A4 (en) | Method of instantizing amino acids | |
ZA201401140B (en) | Polypeptide separation methods | |
EP2802654A4 (en) | Production of recombinant proteins with simple glycoforms | |
GB201111183D0 (en) | Peptide | |
GB201215124D0 (en) | A method of making a composite structure | |
GB201115910D0 (en) | Peptides | |
EP2877575A4 (en) | Method for production of recombinant human alpha-galactosidase a | |
LU92341B1 (en) | Method of producing a shaped component | |
IL234753B (en) | Method for producing a recombinant peptide and resultant peptide | |
EP2599787A4 (en) | Method for producing peptide | |
EP2695947A4 (en) | Recombinant polypeptide production method | |
EP2865686A4 (en) | Egfr-binding peptide | |
HK1212994A1 (en) | Method for producing a cyclic peptide | |
SG11201405721VA (en) | Method of producing a recombinant peptide | |
EP2737065A4 (en) | Protein production method | |
EP2688913A4 (en) | High level production of recombinant proteins | |
EP2599786A4 (en) | Method for producing peptide |